title: Cell density regulates crypticity of GM3 ganglioside on human glioma cells.
abstract: Human glioma cell line KG-1C contains GM3 ganglioside as its sole glycolipid. The degree of M2590 antibody binding to GM3 was found to be regulated by the cell density; the percentage of positive cells in FACS analysis decreased from approximately 20% to close to none as the cells increased their density from sparse to confluent. The contents of GM3 with different cell densities were consistent, being more than 0.4 micromol/g of the cellular weight, which was high enough to be recognized by the antibody. Trypsin treatment of the cells did not increase antibody reactivity. The extracted GM3 retained its antigenicity, being intensely stained with M2590 on a TLC plate; there was no change in chromatographic mobility either, indicating no modification of its chemical structure. The fluorescent microscope disclosed scattered dot-like staining of GM3, particularly at the periphery of the cells. We were able to expose cryptic GM3 fully within 12 h by dispersion of the cells to a sparse density. Surface labeling of GM3 with the use of limited sodium periodate oxidation of sialylated residue equally labeled GM3 either from the confluent cells or the sparse cells. Disassembly of actin filaments with cytochalasin B (10 microM) partially exposed cryptic GM3 of confluent cells, indicating reversibility of the crypticity. All together, the results indicate that cryptic GM3 actually exists on the cell surface, hidden from the surface not by other molecules but by other mechanisms associated with the cellular architecture. We are beginning to explore the possibility of selective localization of GM3 in small caves or folds of the cell membrane produced upon cell-to-cell contact.
authors.affiliation: Department of Neurosurgery, Sapporo Medical University School of Medicine, Hokkaido, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Tatewaki
authors.forename: T
authors.initials: T
authors.lastname: Yamaki
authors.forename: Y
authors.initials: Y
authors.lastname: Maeda
authors.forename: H
authors.initials: H
authors.lastname: Tobioka
authors.forename: H
authors.initials: H
authors.lastname: Piao
authors.forename: H
authors.initials: H
authors.lastname: Yu
authors.forename: Y
authors.initials: Y
authors.lastname: Ibayashi
authors.forename: N
authors.initials: N
authors.lastname: Sawada
authors.forename: K
authors.initials: K
authors.lastname: Hashi
mesh_terms: D000951:Antigens, Neoplasm / Q000096:biosynthesis*; D014408:Biomarkers, Tumor / Q000096:biosynthesis*; D002452:Cell Count; D002462:Cell Membrane / Q000737:chemistry / Q000648:ultrastructure; D003571:Cytochalasin B / Q000494:pharmacology; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D005679:G(M3) Ganglioside / Q000096:biosynthesis* / Q000276:immunology; D005910:Glioma / Q000737:chemistry / Q000378:metabolism*; D006017:Glycolipids / Q000737:chemistry; D006801:Humans; D009439:Neuraminidase / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D005679:G(M3) Ganglioside; D006017:Glycolipids; D003571:Cytochalasin B; D009439:Neuraminidase